Exploring the unique function of imprinting control centers in the PWS/AS-responsible region: finding from array-based methylation analysis in cases with variously sized microdeletions.


Journal

Clinical epigenetics
ISSN: 1868-7083
Titre abrégé: Clin Epigenetics
Pays: Germany
ID NLM: 101516977

Informations de publication

Date de publication:
28 02 2019
Historique:
received: 28 12 2018
accepted: 14 02 2019
entrez: 2 3 2019
pubmed: 2 3 2019
medline: 22 1 2020
Statut: epublish

Résumé

Human 15q11-13 is responsible for Prader-Willi syndrome (PWS) and Angelman syndrome (AS) and includes several imprinted genes together with bipartite elements named AS-IC (imprinting center) and PWS-IC. These concertedly confer allele specificity on 15q11-13. Here, we report DNA methylation status of 15q11-13 and other autosomal imprinted differentially methylated regions (iDMRs) in cases with various deletions within the PWS/AS-responsible region. We performed array-based methylation analysis and examined the methylation status of CpG sites in 15q11-13 and in 71 iDMRs in six cases with various microdeletions, eight cases with conventional deletions within 15q11-13, and healthy controls. We detected 89 CpGs in 15q11-13 showing significant methylation changes in our cases. Of them, 14 CpGs in the SNORD116s cluster presented slight hypomethylation in the PWS cases and hypermethylation in the AS cases. No iDMRs at regions other than 15q11-13 showed abnormal methylation. We identified CpG sites and regions in which methylation status is regulated by AS-IC and PWS-IC. This result indicated that each IC had unique functions and coordinately regulated the DNA methylation of respective alleles. In addition, only aberrant methylation at iDMRs in 15q11-13 leads to the development of the phenotypes in our cases.

Sections du résumé

BACKGROUND
Human 15q11-13 is responsible for Prader-Willi syndrome (PWS) and Angelman syndrome (AS) and includes several imprinted genes together with bipartite elements named AS-IC (imprinting center) and PWS-IC. These concertedly confer allele specificity on 15q11-13. Here, we report DNA methylation status of 15q11-13 and other autosomal imprinted differentially methylated regions (iDMRs) in cases with various deletions within the PWS/AS-responsible region.
METHODS
We performed array-based methylation analysis and examined the methylation status of CpG sites in 15q11-13 and in 71 iDMRs in six cases with various microdeletions, eight cases with conventional deletions within 15q11-13, and healthy controls.
RESULTS
We detected 89 CpGs in 15q11-13 showing significant methylation changes in our cases. Of them, 14 CpGs in the SNORD116s cluster presented slight hypomethylation in the PWS cases and hypermethylation in the AS cases. No iDMRs at regions other than 15q11-13 showed abnormal methylation.
CONCLUSIONS
We identified CpG sites and regions in which methylation status is regulated by AS-IC and PWS-IC. This result indicated that each IC had unique functions and coordinately regulated the DNA methylation of respective alleles. In addition, only aberrant methylation at iDMRs in 15q11-13 leads to the development of the phenotypes in our cases.

Identifiants

pubmed: 30819260
doi: 10.1186/s13148-019-0633-1
pii: 10.1186/s13148-019-0633-1
pmc: PMC6396496
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

36

Références

Genome Res. 2014 Apr;24(4):554-69
pubmed: 24402520
Proc Natl Acad Sci U S A. 2012 May 8;109(19):7403-8
pubmed: 22529396
Nat Genet. 2008 Jun;40(6):719-21
pubmed: 18500341
Hum Mol Genet. 2013 Nov 1;22(21):4318-28
pubmed: 23771028
Bioinformatics. 2014 Feb 01;30(3):428-30
pubmed: 24336642
Am J Hum Genet. 2016 Sep 1;99(3):555-566
pubmed: 27569549
Mol Cell. 2012 Oct 26;48(2):219-30
pubmed: 22959273
Nat Rev Neurol. 2016 Oct;12(10):584-93
pubmed: 27615419
Am J Med Genet A. 2008 Aug 15;146A(16):2041-52
pubmed: 18627066
Clin Genet. 2017 Oct;92(4):440-443
pubmed: 28266014
Genome Res. 2010 Sep;20(9):1271-8
pubmed: 20631049
Eur J Hum Genet. 2015 Feb;23(2):252-5
pubmed: 24916642
Nat Commun. 2018 Apr 24;9(1):1616
pubmed: 29691382
Am J Med Genet C Semin Med Genet. 2010 Aug 15;154C(3):365-76
pubmed: 20803659
Hum Mol Genet. 2009 Sep 1;18(17):3257-65
pubmed: 19498035
Proc Natl Acad Sci U S A. 2015 Jun 2;112(22):6871-5
pubmed: 25378697
Am J Hum Genet. 2003 Mar;72(3):571-7
pubmed: 12545427
PLoS One. 2010 Jul 26;5(7):e11779
pubmed: 20668672
Eur J Hum Genet. 2010 Nov;18(11):1196-201
pubmed: 20588305
Genet Med. 2012 Jan;14(1):10-26
pubmed: 22237428

Auteurs

Keiko Matsubara (K)

Department of Molecular Endocrinology, National Center for Child Health and Development, 2-10-1 Ohkura, Setagaya-ku, Tokyo, 157-8535, Japan. matsubara-k@ncchd.go.jp.

Masatsune Itoh (M)

Department of Pediatrics, Kanazawa Medical University, Kanazawa, 920-1192, Japan.

Kenji Shimizu (K)

Division of Medical Genetics, Saitama Children's Medical Center, Saitama, 330-8777, Japan.

Shinji Saito (S)

Department of Pediatrics and Neonatology, Nagoya City University Graduate School of Medical Sciences, Nagoya, 467-8601, Japan.

Keisuke Enomoto (K)

Enomoto Children's Clinic, Moriya, 302-0127, Japan.
Department of Pediatrics and Developmental Biology, Tokyo Medical and Dental University Graduate School, Tokyo, 113-8510, Japan.

Kazuhiko Nakabayashi (K)

Department of Maternal-Fetal Biology, National Center for Child Health and Development, Tokyo, 157-8535, Japan.

Kenichiro Hata (K)

Department of Maternal-Fetal Biology, National Center for Child Health and Development, Tokyo, 157-8535, Japan.

Kenji Kurosawa (K)

Division of Medical Genetics, Kanagawa Children's Medical Center, Yokohama, 232-8555, Japan.

Tsutomu Ogata (T)

Department of Molecular Endocrinology, National Center for Child Health and Development, 2-10-1 Ohkura, Setagaya-ku, Tokyo, 157-8535, Japan.
Department of Pediatrics, Hamamatsu University School of Medicine, Hamamatsu, 431-3192, Japan.

Maki Fukami (M)

Department of Molecular Endocrinology, National Center for Child Health and Development, 2-10-1 Ohkura, Setagaya-ku, Tokyo, 157-8535, Japan.

Masayo Kagami (M)

Department of Molecular Endocrinology, National Center for Child Health and Development, 2-10-1 Ohkura, Setagaya-ku, Tokyo, 157-8535, Japan. kagami-ms@ncchd.go.jp.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH